Clinical Trial Update: Single-dose Safety Study of APD916 in Healthy Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 single-dose safety study of APD916 in healthy volunteers has completed. The trial listed narcolepsy with or without cataplexy as the associated condit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Narcolepsy with or Without Cataplexy

Drugs mentioned

• APD916

Snippet

Sponsor: Arena Pharmaceuticals | Conditions: Narcolepsy With or Without Cataplexy | Phase 1 | Status: COMPLETED